AMREP Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AMREP Corporation (AMREP) on November 2, 2021, covering events occurring on November 1, 2021. The filing discloses the execution of a new employment agreement and a stock option grant for Christopher V. Vitale, the Company's President and Chief Executive Officer.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes and Executive Compensation
On November 1, 2021, AMREP entered into a new Employment Agreement with Christopher V. Vitale. Key terms include:
- Base Salary: Not less than $335,000 per year.
- Severance (Termination without Cause/Good Reason): A lump sum equal to 200% of the highest applicable annual base salary (current, 210 days prior, or pre-cause event) plus immediate full vesting of all outstanding equity awards.
- Death Benefit: Payment of one month's salary plus three months' salary to executors.
- Disability/Severance Health Benefits: A lump sum equal to 200% of the annual cost of medical and healthcare benefits for the executive and dependents, plus estimated taxes.
- Indemnification: Full defense and indemnification for legal proceedings related to his role, with D&O insurance coverage for up to six years post-termination.
Additionally, the Company granted Mr. Vitale an option to purchase 50,000 shares of common stock under the 2016 Equity Compensation Plan:
- Exercise Price: $14.24 per share (closing price on November 1, 2021).
- Vesting: 100% exercisable on November 1, 2026, provided he remains employed.
- Acceleration: Immediate 100% exercisability upon death, disability, termination without cause, or a change in control.
- Term: Ten years from the grant date.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business operations. The primary risk disclosed relates to the potential future cash outflows associated with the severance provisions and equity acceleration if Mr. Vitale's employment is terminated under specific conditions (without cause, for good reason, or due to death/disability).
Key Facts for Investor Verification
- Verify the total potential severance liability (200% of salary) in the event of a termination without cause.
- Confirm the impact of the 50,000 share option grant on potential dilution and future compensation expense.
- Review the definition of "Good Reason" to understand the triggers for accelerated vesting and severance payments.
- Check the Company's current cash position to assess its ability to fund the lump-sum severance payments if triggered.